Senior Director, Global Real-World Evidence & Health Outcomes Research Lead, Specialty Medicines - Respiratory
GSK
Summary
Robust real-world evidence and health outcomes data is necessary to support launch optimization, reimbursement and maintain market position in today's healthcare environment. Evidence must be developed throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors.
Job description
The role of Senior Director, Global Real-World Evidence & Health Outcomes Research (GRWE&HO) Lead, Respiratory, will provide strategic real-world evidence and health outcomes leadership for assigned Respiratory asset(s) and is critical to ensuring that each medicine GSK brings to market is supported by scientifically credible, high-quality evidence that drives competitiveness and strong evidence-based product positioning, value propositions and value-based pricing.
Key Responsibilities
- Key member of the Global Real-World Evidence & Health Outcomes Research Specialty LT and other relevant matrix leadership teams.
- Accountable for ensuring team members engage closely with medical and matrix stakeholders and partner effectively in evidence strategy and data generation plan (DGP) planning, design, execution, translation, and dissemination for assigned Respiratory asset(s).
- Build trusted relationships with key stakeholders, positioning GRWE&HO as a strategic partner and source of scientific and methodological expertise.
- Provide leadership, management, and development of Data Generation book of work, including development of integrated real-world evidence and health outcomes strategies across the asset lifecycle.
- Partner and communicate effectively with matrix stakeholders in planning and design of the DGP for the asset, drive disciplined execution of studies and activities, translate results, and disseminate data and research findings.
- Provide scientific leadership for best practice in real world evidence, including non-interventional and pragmatic/hybrid interventional study approaches.
- Drive innovation and inform ideas and options through effective engagement with external experts, clinical guideline groups, HTA agencies, methodology and policy forums.
- Integrate excellent understanding of the evolving global health technology assessment bodies, clinical guidelines groups, policy decision makers and payer environment.
- Lead discussions with key stakeholders on prioritization of data generation to meet business and customer needs.
- Deliver materials to inform internal governance decision making with the ability to communicate complex evidence strategies at an executive level.
- Facilitate alignment and partnership within the complex stakeholder matrix, e.g. clinical, commercial, market access, medical affairs functions, priority market LOCs and external third-party suppliers.
- Represent GSK in external collaborations, engagement and scientific evidence requirements with scientific partners, reimbursement bodies and other decision makers.
- Drive quality and compliance through team to ensure trust for the evidence that is delivered.
- Drive discipline in performance reporting and ensure studies are delivered according to plan and within budget.
Basic Qualifications
- PhD, PharmD or equivalent level qualification in epidemiology, health outcomes, patient reported outcomes, health economics, pharmacy, or health sciences.
- Considerable experience working in global pharmaceuticals in a leadership role with line management experience.
- Experience within the respiratory therapeutic area or a closely related field.
- Strong business acumen and ability to translate customer needs into actionable data generation plan and integrated evidence strategies.
- Methods expertise to guide and lead team in delivering robust real-world evidence and payer evidence deliverables.
- Knowledge of the diversity and complexity of healthcare markets, health technology assessment agencies, and reimbursement decision making globally, in region and in local markets.
- Understanding of how real-world evidence, health economics, health outcomes, comparative effectiveness research, PRO research and the use of PRO instruments can be applied at local decision-making levels.
- Deep knowledge and strong communication skills for interpreting and translating complex concepts and results effectively to a variety of audiences, including senior executives.
- Strong matrix leadership and stakeholder management skills, with the ability to work independently and build trusted strategic partnerships.
- Experience across product lifecycles.
- Deep knowledge of drug development and therapy area.
- Experience leading a complex portfolio of projects, stakeholders, and other analytic staff in a senior role.
- Demonstrated experience building external scientific collaborations and engaging effectively with leading external experts, academic institutions, research networks, and other scientific partners.
Preferred Qualifications
- Experience in above country and in country roles.
- Direct experience with, or strong familiarity with, pragmatic clinical trials, hybrid interventional/real-world study designs, and other innovative approaches to evidence generation.
- Experience supporting assets in complex competitor landscapes.
- Direct payer experience.
- Launch experience.
- Portfolio of high value publications and/or scientific promotions.
Requirements
- PhD, PharmD or equivalent level qualification in epidemiology, health outcomes, patient reported outcomes, health economics, pharmacy, or health sciences
- Considerable experience working in global pharmaceuticals in a leadership role with line management experience
- Experience within the respiratory therapeutic area or a closely related field
- Strong business acumen and ability to translate customer needs into actionable data generation plan and integrated evidence strategies
- Methods expertise to guide and lead team in delivering robust real-world evidence and payer evidence deliverables
- Knowledge of healthcare markets, health technology assessment agencies, and reimbursement decision making globally, in region and in local markets
- Understanding of real-world evidence, health economics, health outcomes, comparative effectiveness research, PRO research and PRO instruments
- Strong communication skills for interpreting and translating complex concepts to senior executives
- Strong matrix leadership and stakeholder management skills
- Experience across product lifecycles
- Deep knowledge of drug development and therapy area
- Experience leading a complex portfolio of projects, stakeholders, and analytic staff in a senior role
- Demonstrated experience building external scientific collaborations and engaging with external experts, academic institutions, and research networks
Benefits
- Agile working culture
- Flexible work arrangements
Company overview
GSK plc (formerly GlaxoSmithKline) is a British multinational pharmaceutical and biotechnology company headquartered in London, England. Founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, GSK has grown to become one of the world's leading healthcare companies with operations in over 150 countries. The company specializes in researching, developing, and manufacturing prescription medicines, vaccines, and consumer healthcare products. GSK's therapeutic areas include respiratory diseases, HIV/AIDS, oncology, immunology, and infectious diseases. The company is particularly renowned for its vaccine portfolio and has been at the forefront of developing treatments for major global health challenges. With approximately 70,000 employees worldwide, GSK maintains a strong commitment to scientific innovation and has a significant presence in key markets including the United States, Europe, and emerging economies. The company's mission is to unite science, technology, and talent to get ahead of disease together, aiming to positively impact the health of 2.5 billion people by the end of the decade.